MEDT, NCNC, CNWI, PWRM, BGMO, ZIPN OTCPicks.com Stocks to Watch for Friday, September 4th

Our Stocks to Watch tomorrow include MediaTechnics Corp. (OTC: MEDT), New Century Companies Inc. (OTCBB: NCNC), Cardiac Network Inc. (OTC: CNWI), Power3 Medical Products Inc. (OTCBB: PWRM), Bergamo Acquisition Corp. (OTC: BGMO) and Zippi Networks Inc. (OTC: ZIPN).

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

MEDIATECHNICS CORPORATION (OTC: MEDT)

"Up 89.47% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/MEDT.php

Mediatechnics Corporation (www.mediatechnicscorporation.com) is the parent company of Mediatechnics Systems Inc., MediaMaster Corporation, The Live Network, Innotech and CRD Technology.

MEDT News:

September 3 - MediaTechnics Updates Shareholders on Corporate Vision, Restructuring Plans

MediaTechnics Corporation (OTC: MEDT) is pleased to announce we have begun the process of expanding our line of products and services. We are also currently reviewing several potential merger and acquisition opportunities.

Management intends to update shareholders, as events warrant through more regular announcements in the coming weeks and months, as part of our plan for growth for the rest of 2009 and beyond.

CEO Rick Wilson stated, "Although 2009 sales have been significantly impacted by the decline in the state of the nation's economy, I believe we are on the way towards becoming a stronger and growing company."

The company has updated its quarterly financials with Pink Sheets and intends to begin filing updates to its financials on a timelier basis.

"I am excited about the future of MediaTechnics," Wilson continued. "We hope to complete the restructuring and expansion of our business model in order to substantially strengthen our bottom line."

The company intends to continue converting substantial portions of debt to equity in order to increase shareholder value.

NEW CENTURY COMPANIES INCORPORATED (OTCBB: NCNC)

"Up 217.65% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/NCNC.php

New Century Companies, Inc. is one of the leading U.S.-based makers of machine tools, primarily vertical boring mills and large lathes such as vertical turning centers (VTCs). It specializes in re-manufacturing, starting with existing major castings and fitting them with state-of-the-art, computer-controlled equipment. These products generally cost 40% to 60% less to manufacture than new ones. New Century passes these savings on to its customers, which include such leading manufacturers as General Electric Co., General Dynamics Corp., Siemens AG and Gardner Denver. New Century machines are used to manufacture jet engine components, airplane landing gear parts, power generation equipment, oil and gas production components and construction materials, to name just a few applications. New Century's production facility is in Santa Fe Springs, CA.

NCNC News:

September 3 - New Century Companies to Acquire Precision Aerostructures, Inc.

New Century Companies, Inc. (OTCBB: NCNC) announced that it has signed a definitive agreement to acquire Precision Aerostructures, Inc. through a cashless merger. Russell Armstrong, Crescent Financial Advisors, Inc., has facilitated the negotiations of the merger and will conduct and assist with all aspects of the transaction.

Precision Aerostructures, Inc. manufactures structural aircraft components and assemblies. The company's customers do business in defense, government systems, aerospace and commercial markets. The company's web site is www.precisionaerostructures.com.

David Duquette, CEO, New Century Companies, Inc., stated, "We are pleased to have found a great company to grow our business. Precision Aerostructures, Inc. has an excellent management team and a backlog of $27,000,000 in contracts. We expect the combined companies to have earnings in the next 12 months in excess of $.12 per share. The closing, expected shortly, is subject to certain financing conditions and final due diligence, as is the case in any merger."

CARDIAC NETWORK INCORPORATED (OTC: CNWI)

"Up 50.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/CNWI.php 

Cardiac Network, Inc. is a medical technology company providing cardiac monitoring and diagnostic services to general practitioners and specialist physicians, for the investigation of patients with abnormal cardiac rhythm and function. The service uses unique transtelephonic (by telephone) cardiac recorders that monitor and provide diagnostic information to physicians and their patients. Cardiac Network also offers its services and advanced mobile technology to individuals which help them quickly determine if they are having potential cardiac problems so that they can obtain immediately needed medical treatment.

CNWI News:

June 26 - Cardiac Network Welcomes Honored Cardiac Surgeon to Its Advisory Board of Industry Experts

Cardiac Network, Inc. (OTC: CNWI) announced the addition of an honored cardiac surgeon to the company's advisory board. Fardad Esmailian, MD, is from UCLA Medical Center and will be advising the Company on its clinical programs and value-added services for Cardiac Network's HeartOne Club.

Dr. Esmailian currently serves as a Clinical Professor of Surgery at UCLA Medical Center, Division of Cardiothoracic Surgery, and is a practicing Board Certified Cardiothoracic Surgeon. Dr. Esmailian obtained his M.D. degree from The George Washington University School of Medicine in Washington, D.C., and did his Residency in Cardiothoracic Surgery at the University of California, Los Angeles. He was the Director of Cardiac Surgery at UCLA-Santa Monica Hospital, California, from July 1999 to July 2007, and Chief, Division of Cardiothoracic Surgery, at Wadsworth VA Medical Center in Los Angeles from July 1996 to July 1999. Dr. Esmailian has served on the Department of Surgery Finance Committee and Medical School Admissions Subcommittee at UCLA Medical Center. He has received research awards and been featured in various publications in the areas of cardiac surgery and heart transplantation, and is often an invited speaker in conferences and media programs.

"Dr. Esmailian will be a tremendous complement to the advisory board that contains experts from the financial, regulatory and medical fields. This advisory group will be critical in guiding our company through its rapid growth," said Michael Swartzburg, President & CEO of Cardiac Network, Inc.

Cardiac Network will continue to reach out to the industry advisors to provide ongoing assistance with its expanding medical and technology services platform.

POWER 3 MEDICAL PRODUCTS INCORPORATED (OTCBB: PWRM)

"Up 54.64% on Thursday"

Detailed Quote: www.otcpicks.com/quotes/PWRM.php 

Power3 Medical Products Inc. is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

PWRM News:

September 2 - Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson's Disease

On-line Publication of Biomarker Panel that Forms Basis for NuroPro®PD Diagnostic Test

Transgenomic, Inc. (OTCBB: TBIO) and Power3 Medical Products, Inc. (OTCBB: PWRM) announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson's disease (PD) patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.

The analytic technology forms the basis for the NuroProPD test for PD being commercialized by Transgenomic as per a licensing/collaboration agreement with Power3 Medical signed in early 2009. The publication of the peer-reviewed article is a significant validation milestone in the ongoing clinical development of the NuroProPD diagnostic assay.

The article describes the use of analytically validated quantitative 2D gel electrophoresis to identify protein biomarkers for diagnosing PD using serum from routinely collected blood samples. 57 protein biomarkers, which had been discovered using retrospective blood serum samples from various neurodegenerative diseases, were then applied specifically to PD in a prospective clinical investigation using freshly collected blood serum from PD patients and age-matched normal controls. A multi-variate statistical method, stepwise linear discriminant analysis, selected a combination of 21 of the biomarkers as optimal to distinguish PD patients from controls. When applied to the PD samples, the 21-protein set had sensitivity of 93.3% (52 of 56 PD correctly classified) and specificity of 92.9% (28 of 30 controls correctly classified); 15 of 15 patients with mild and 28 of 30 with moderate to severe symptoms were correctly classified, as were all 6 PD samples from an independent site.

"We are enthusiastic about the acceptance of our paper in this established peer-reviewed scientific journal. It represents independent external validation of the clinical data, and so increases the confidence that we have in NuroProPD to be a meaningful tool for the diagnosis of Parkinson's disease, especially early in its course," said Craig Tuttle, CEO of Transgenomic. "We are completing the clinical validation of the assay in our CLIA-certified molecular testing laboratory and will be launching the assay in the very near future."

"In the U.S., there are an estimated 1.5 million individuals with Parkinson's disease. Unfortunately, by the time patients are given a probable diagnosis, many have already suffered substantial and irreparable brain damage, rendering treatment less effective," said Dr. Ira Goldknopf, President and CSO of Power3 Medical and lead author on the paper. "The fact that these results were obtained using fresh blood serum, in the same way that the test will be performed in a clinical diagnostic setting, provides further support for their robustness and their commercial value."

Clinical investigators in the study were Dr. Katerina Markopoulou of the University of Thessaly, Greece, Drs. Marwan Sabbagh and Holly Shill of Banner Sun Health Research Institute, Sun City, Arizona, and Dr. Stanley Appel of the Texas Methodist Health System, Houston.

ABOUT TRANSGENOMIC, INC.

Transgenomic, Inc. (OTCBB: TBIO) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR® Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomic Services is a CRO for pharmacogenomic, translational research and clinical trials.

BERGAMO ACQUISITION CORPORATION (OTC: BGMO)

"Up 64.29% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/BGMO.php 

Bergamo Acquisition Corp., through its wholly owned subsidiary, Bergamo E&A Corp., focuses on the development of clean energy infrastructure projects in Pakistan. The company involves in the construction of mission-critical infrastructure, including clean energy electric plants, solar renewable energy projects, and LED high efficiency lighting projects. It also provides construction management and facility maintenance services. In addition, Bergamo Acquisition Corp. engages in wholesale business that focuses on women’s urban fashion apparel and accessories comprising recognized brands. The company is headquartered in Henderson, Nevada.

BGMO News:

September 2 - Bergamo Acquisition Corp. CEO Hillard Herzog Today Featured in Podcast Interview

Hillard Herzog, CEO of Bergamo Acquisition Corp. (OTC: BGMO), was featured in a podcast interview on StockGuru.com released after the close of market on Wednesday. In the interview, Mr. Herzog gave additional details and further explained the $1 billion USD investment into Bergamo's wholly owned subsidiary, Bergamo E & A, as announced on Tuesday. Mr. Herzog also discussed the status of the $100 million USD domestic funding announced on July 27, 2009.

To listen to the interview, visit www.stockguru.com/2009/09/bgmo-hillard-herzog.

On Friday, September 4, 2009 at 1:40 PM Pacific Time Mr. Herzog will also appear live on "The Big Biz Show" with Sully on the Business Talk Radio Network. To find out more and to listen live, check out www.bigbizshow.com.

ZIPPI NETWORKS INCORPORATED (OTC: ZIPN)

"Up 50.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/ZIPN.php

Zippi™ Networks, Inc., headquartered in San Jose, Calif. and founded in 2006, is a leading provider of mobile commerce applications that create jobs and enable Americans to recycle their "Clutter into Cash". This revolutionary business process has three US Patents Pending and promises to engage consumers with the ease of a toll free Hotline that takes the guess work out of pricing and selling items online. Zippi allows consumers of all ages to "Free Themselves" advanced mobile technology allows everyone an easy hassle free way of turning clutter into cash, recycling, and earning an income with the Zippi Network. The "Zippi Cash" mobile iPhone application is the first in a consumer line of products that provides appraisal information to an item owner prior to listing. Zippi Cash will also connect directly to the seller network to handle the entire transaction for those who wish to cash in without the hassle of actually listing and selling themselves. Zippi's mobile commerce applications allow the user to list items themselves and build income for a complete home based business in the palm of their hand.

ZIPN News:

September 2 - Zippi Continues Reducing Costs by Test Marketing Channels and Updating Products for Electronic Distribution and Fulfillment

Zippi Networks Inc. (OTC: ZIPN), a leading provider of mobile, web-based, and telecommunications based commerce applications that enable Americans to recycle their "Clutter into Cash," announced its continued efforts in testing marketing campaigns and sales strategies, while upgrading and re-tooling to enable electronic distribution of its products and services, which has now been completed.

Zippi has been promoting and selling its products and services in the marketplace for over two (2) years now, utilizing a variety of marketing strategies combined with various forms of media to measure response rates. The company has made certain internal changes and shifts in its expenses to further reduce outstanding debt and more efficiently run its operations while marketing to its target audience. By better defining product and service functionality, automating processes, and re-tooling products that were being traditionally fulfilled Zippi has significantly reduced product and shipping costs when completing sales. Additionally the company will seek a new facility with lower monthly lease obligations as its current lease expires in October of 2009.

Robert A. Rositano Jr., CEO Zippi Networks, Inc., stated "Streamlining our efforts across the board allows us to better service debt holders and vendors that have shown tremendous patience with Zippi as we have held on tight through some very tough market conditions. These efforts have also allowed us to better target the two types of customers Zippi is seeking, at a much lower cost per acquisition or (CPA) as we know internally and our shareholders know from following the company this has not been an overnight task. Although I had hoped we could complete these changes more quickly I am very happy with the results, adding partners that will market the Zippi products and services becomes the next key ingredient to a successful offering and re-launch of our products and services."

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: OTCPicks.com has been compensated two thousand five hundred dollars from BlueWave Advisors for CNWI advertising and promotional services.